NLM Logo

Carnitine palmitoyl transferase 2 deficiency MeSH Supplementary Concept Data 2024


MeSH Supplementary
Carnitine palmitoyl transferase 2 deficiency
Unique ID
C535589
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/C535589
Entry Term(s)
Carnitine Palmitoyltransferase 2 Deficiency
Carnitine Palmitoyltransferase Ii Deficiency
Carnitine palmitoyltransferase deficiency type 2
Cpt Ii Deficiency
Cpt2 Deficiency
Muscle form of carnitine palmitoyltransferase deficiency
Registry Number
0
Heading Mapped to
Carnitine O-Palmitoyltransferase / *deficiency
*Metabolism, Inborn Errors
Frequency
69
Note
Three autosomal recessive forms of this disorder caused by mutations in the CPT2 gene occur: The lethal neonatal form (OMIM: 608836) is characterized by RESPIRATORY FAILURE; SEIZURES; LIVER FAILURE; CARDIOMYOPATHY, and ARRHYTHMIA and is fatal in the first few days or months of life. The infantile form (OMIM: 600649) also affects the heart, liver, and muscles and can result in severe symptoms or death during FASTING or VIRAL INFECTION. The most common myopathic form (OMIM: 255110) occurs in young adults and is characterized by recurrent episodes of RHABDOMYOLYSIS triggered by prolonged exercise, fasting, or febrile illness.
Date of Entry
2010/08/25
Revision Date
2015/08/17
Carnitine palmitoyl transferase 2 deficiency Preferred
page delivered in 0.005s